Mapema SA
1.6 FTEThe score of Mapema shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +104 % Headcount (avg FTE) +167 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mapema's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Oct 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 19 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
Mapema's financial analysis
- Solvency2.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mapema
Mapema's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0472.045.946
- VAT number
- BE0472045946
- Peppol
- Registered · 0208:0472045946 · as of 05 Nov 2026
- Legal form
- SA
- Incorporated
- 05 Jun 2000
- Registered office
- 3621 Lanaken
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2025 · filed on 28 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Mapema (SA) has been based in Lanaken since 2000, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 9,230 € and equity of 154,143 €; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 2.5%, below the median of its sector (44.2%).
Companies similar to Mapema
Companies in the same business, of comparable size and area, outside its group.
- Departement Central DE Fractionnement Manufacture of pharmaceutical preparations Brussels · balance sheet €19.7m
- Orthophysics Manufacture of medical and dental instruments and supplies Hooglede · balance sheet €2.78m
- OVUM Bxl Public relations and communication activities Uccle · balance sheet 776,837 €
- HrC Services Public relations and communication activities Sint-Martens-Latem · balance sheet 276,054 €
- QP Pro Services Manufacture of basic pharmaceutical products Gembloux · balance sheet 304,804 €
- Belem Consulting Business and other management consultancy activities Liège · balance sheet 45,666 €
- ACP-Pharma Retail sale of pharmaceutical products Affligem · balance sheet 48,017 €
- Medisphere Wholesale of pharmaceutical and medical goods Hamois · balance sheet €6.04m
Frequently asked questions about Mapema
What is the revenue of Mapema?
Mapema files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mapema?
In Belgium, the VAT number is the company number prefixed with BE: BE0472045946 for Mapema, if the company is VAT-registered. Its company number (CBE) is 0472.045.946.
Where is the registered office of Mapema?
According to the CBE register, the registered office of Mapema is in 3621 Lanaken.
What is the equity of Mapema?
At the close of the 2025 financial year, the equity of Mapema amounts to 154,143 €, a solvency of 2.5% of total assets.
How many people work at Mapema?
1.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Mapema?
The register lists 1 active mandates at Mapema. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mapema
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →